Harbour Capital Advisors’s Medtronic MDT Stock Holding History

Harbour Capital Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,943	Closed	-$216K	–	229
2022 Q1	$216K	Hold	1,943	–	–	0.06%	215
2021 Q4	$201K	Buy	+1,943	New	+$225K	0.05%	233
2020 Q1	–	Sell	-3,218	Closed	-$365K	–	192
2019 Q4	$365K	Buy	+3,218	New	+$353K	0.14%	158
2017 Q2	–	Sell	-1,906	Closed	-$154K	–	456
2017 Q1	$154K	Buy	+1,906	New	+$149K	0.07%	235
2016 Q4	–	Sell	-2,105	Closed	-$182K	–	226
2016 Q3	$182K	Buy	+2,105	New	+$183K	0.11%	192
2016 Q2	–	Sell	-6,963	Closed	-$522K	–	232
2016 Q1	$522K	Buy	+6,963	New	+$524K	0.3%	114

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Harbour Capital Advisors's MDT Position: Q2 2022 in Review

Harbour Capital Advisors sold out of Medtronic (MDT) in Q2 2022, closing a stake of 1,943 shares — an estimated $216K sold.

Harbour Capital Advisors first reported a position in MDT in Q1 2016 and held it in 6 quarters. The position peaked at $522K in Q1 2016. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

Harbour Capital Advisors reported no remaining Medtronic position as of Q2 2022 after selling out during the quarter.
Harbour Capital Advisors sold 1,943 Medtronic shares in Q2 2022, an estimated $216K.
Harbour Capital Advisors first reported a position in Medtronic in Q1 2016 and held it in 6 quarters.
Harbour Capital Advisors's Medtronic position peaked at $522K in Q1 2016.
2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Harbour Capital Advisors's 13F filing for Q2 2022, filed 20 Jul 2022.